Cargando…
Targeting DNA binding proteins for cancer therapy
Dysregulation or mutation of DNA binding proteins such as transcription factors (TFs) is associated with the onset and progression of various types of disease, including cancer. Alteration of TF activity occurs in numerous cancer tissues due to gene amplification, deletion, and point mutations, and...
Autores principales: | Shiroma, Yoshitomo, Takahashi, Ryou‐u, Yamamoto, Yuki, Tahara, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156841/ https://www.ncbi.nlm.nih.gov/pubmed/32073717 http://dx.doi.org/10.1111/cas.14355 |
Ejemplares similares
-
Identification of a Selective RelA Inhibitor Based on DSE-FRET Screening Methods
por: Shiroma, Yoshitomo, et al.
Publicado: (2020) -
Diagnostic performance of peripheral leukocyte telomere G‐tail length for detecting breast cancer
por: Koi, Yumiko, et al.
Publicado: (2020) -
Leukocyte Telomeric G-Tail Length Shortening Is Associated with Esophageal Cancer Recurrence
por: Han, Jiayan, et al.
Publicado: (2022) -
PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA
por: Yano, Kimiyoshi, et al.
Publicado: (2021) -
Association Between Telomere G-Tail Length and Coronary Artery Disease or Statin Treatment in Patients With Cardiovascular Risks ― A Cross-Sectional Study ―
por: Nose, Daisuke, et al.
Publicado: (2023)